Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  GlaxoSmithKline plc    GSK   GB0009252882

Delayed Quote. Delayed  - 05/27 05:35:05 pm
1452.5 GBp   -0.31%
05/27DJGLAXOSMITHKLINE : Says European Commission Approves Stem-Cell Therap..
05/27 GLAXOSMITHKLINE : StrimvelisTM receives European marketing authorisa..
05/27 GLAXOSMITHKLINE : Glaxo's Strimvelix Gene Therapy Gets European Mark..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

GlaxoSmithKline And University Of Nottingham Establish Research Center

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/26/2012 | 10:46am CEST

Drug maker GlaxoSmithKline PLC (>> GlaxoSmithKline plc) and the University of Nottingham said Thursday that they formalized a collaboration to establish a new laboratory to accommodate the Centre of Excellence for sustainable chemistry and to construct an innovative carbon neutral sustainable chemistry laboratory.

MAIN FACTS:

-The Laboratory for Sustainable Chemistry is being supported by a GBP12 million grant from Glaxo.

-Shares at 0829 GMT, down 10 pence, or 0.71%, at 1,403.5 pence valuing the company at GBP71.28 million.

-By Rory Gallivan, Dow Jones Newswires; 44-20-7842-9411; rory.gallivan@dowjones.com

Stocks mentioned in the article : GlaxoSmithKline plc
share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on GLAXOSMITHKLINE PLC
05/27DJGLAXOSMITHKLINE : Says European Commission Approves Stem-Cell Therapy
05/27 GLAXOSMITHKLINE : StrimvelisTM receives European marketing authorisation to trea..
05/27 GLAXOSMITHKLINE : Glaxo's Strimvelix Gene Therapy Gets European Marketing Author..
05/27 GLAXOSMITHKLINE : Strimvelis receives EC marketing authorisation
05/27 GLAXOSMITHKLINE : Board and Committee changes
05/26DJIONIS PHARMACEUTICALS : Shares Fall After Co-Developer Opts Against a Late-Stage..
05/26DJIonis's Shares Fall After Co-Developer Opts Against Starting Late-Stage Trial
05/26 GLAXOSMITHKLINE PAKISTAN : Dispatch of final dividend warrants of GlaxoSmithKlin..
05/26DJIONIS PHARMACEUTICALS : Shares Fall After Co-Developer Opts Against Starting Lat..
05/25 INNOVIVA : Salford Lung Study results show COPD patients treated with Relvar® E..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials